Abstract
Bland et al. show that cancer types with heterozygous somatic hotspot mutations in the spliceosome component SF3B1 are vulnerable to PARP inhibition, ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
